Lab Group Pleased With Wellness, Prevention Parts Of Health Reform Law
This article was originally published in The Gray Sheet
Executive Summary
Independent diagnostic laboratories have much to celebrate with final passage and signing of the health care reform bill, American Clinical Laboratory Association President Alan Mertz said in a March 30 conference call
You may also be interested in...
Chart: Health Care Reform Implementation Timeline
Now that health care reform is a reality, here are some important events for the medical device sector to look out for.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.